Armata Pharmaceuticals, Inc. (ARMP) Dividend History

Armata Pharmaceuticals, Inc. is a biotechnology company focused on developing bacteriophage-based therapies to treat bacterial infections. The company leverages its proprietary platform to create targeted phage products aimed at addressing unmet medical needs, particularly antibiotic-resistant infections. Founded with a focus on innovative approaches to combat bacterial pathogens, Armata aims to offer effective alternatives to traditional antibiotics.

Dividend History

Armata Pharmaceuticals, Inc. currently does not pay dividends

Company News

  • 8MM Bronchiectasis Market Opportunity Assessment and Forecasts, 2033 - Pipeline Innovations Expected to Add $1.8 Billion in Bronchiectasis Market Sales

    The report forecasts the bronchiectasis treatment market to reach $3.7 billion by 2033, driven by emerging pipeline agents expected to contribute an additional $1.8 billion in sales.

    GlobeNewswire Inc.
    Featured Companies: INSM REGN
  • Y-mAbs Therapeutics, Inc. (YMAB) Reports Q3 Loss, Lags Revenue Estimates

    Y-mAbs Therapeutics, Inc. (YMAB) delivered earnings and revenue surprises of -12.50% and 0.53%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?

    Zacks Investment Research
    Featured Companies: YMAB
  • Why Universal Health Services Shares Are Trading Lower By 6%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

    Gainers Silicon Motion Technology Corporation (NASDAQ: SIMO) shares climbed 78.9% to $93.40 following a report suggesting China approval of the company's Maxlinear merger. Mallinckrodt plc (NYSE: MNK) gained 70% to $0.75. Sources said Mallinckrodt is considering bankruptcy as part of plan to avoid paying money it owes opioid victims, according to the Wall Street Journal. SCWorx Corp. (NASDAQ: WORX) surged 50% to $0.3721. ABVC BioPharma, Inc. (NASDAQ: ABVC) gained 48.7% to $5.65. ABVC BioPharma signed a term sheet to advance a partnership with Zhonghui United Technology (Zhonghui) Group Co., Ltd. and its affiliated enterprises. Vicor Corporation (NASDAQ: VICR) shares climbed 48.3% to $88.12 after the company posted better-than-expected second-quarter results. Sigma Additive Solutions, Inc. (NASDAQ: SASI) gained 47% to $0.2761. AERWINS Technologies Inc. (NASDAQ: AWIN) shares gained 37.8% to $0.3329 after declining around 7% on Tuesday. NLS Pharmaceutics AG (NASDAQ: NLSP) climbed 27.3% to $0.9751. PacWest Bancorp (NASDAQ: PACW) shares gained 25.6% to $9.66 after the company announced a merger with Banc of California. PacWest Bancorp also reported upbeat quarterly earnings. Teladoc Health, Inc. (NYSE: TDOC) rose 25.7% to $28.65 following better-than-expected quarterly results. XPeng Inc. (NYSE: XPEV) gained 25% to $19.20 after the company and Volkswagen signed a framework agreement for technical collaboration. Volkswagen will acquire 4.99% of Xpeng's outstanding share capital for $700 million. Armata Pharmaceuticals, Inc. (NYSE: ARMP) rose 21.3% to $2.39. Soluna Holdings, Inc. (NASDAQ: SLNH) jumped 18.8% to $0.3306. PROG Holdings, Inc. (NYSE: PRG) gained 18.8% to $43.11 after the company reported better than expected second-quarter earnings and revised guidance. Flushing Financial Corporation (NASDAQ: FFIC) gained 18.7% to $16.39. Shares of bank stocks traded higher after Banc of California and PacWest announced a merger agreement. WW International, Inc. (NASDAQ: WW) jumped 18.2% to $11.73 after Morgan Stanley ...

    Benzinga
    Featured Companies: ABVC AMG BA EEFT FFIC GOOGL HBI HCSG LAD LGHL LOB MAXN MMSI MSFT MXL NLSP PRG RES RPM SAGE SLAB SLGN SLNH SNAP SPWR TDOC TENB TLRY TXN UHS UNP USNA VICR WAL WM WORX YOSH
  • 1 Healthcare Stock That Could Fly Higher After a Strong Q4

    This pharmaceutical company is growing revenue and profits from drugs it doesn't market or sell.

    The Motley Fool
    Featured Companies: ABBV INVA VRTX
Page data last updated 07/23/2025 08:09:55 UTC